"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
Topically applied VANOS Cream can be absorbed in sufficient amounts to produce systemic effects [see WARNINGS AND PRECAUTIONS].
None.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/29/2016
Additional Vanos Information
Vanos - User Reviews
Vanos User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.